Search Results - "Manzarbeitia, Cosme"

Refine Results
  1. 1

    Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials by CHALASANI, Naga, MANZARBEITIA, Cosme, LOPEZ-TALAVERA, Juan Carlos, FERENCI, Peter, VOGEL, Wolfgang, FONTANA, Robert J, VOIGT, Michael, RIELY, Caroline, MARTIN, Paul, TEPERMAN, Lewis, JIAO, James

    Published in Hepatology (Baltimore, Md.) (01-02-2005)
    “…There is currently no effective treatment for recurrent hepatitis C after orthotopic liver transplantation (OLT). We therefore performed two randomized,…”
    Get full text
    Journal Article
  2. 2

    Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database by Krowka, Michael J., Mandell, M. Susan, Ramsay, Michael A.E., Kawut, Steve M., Fallon, Michael B., Manzarbeitia, Cosme, Pardo, Manuel, Marotta, Paul, Uemoto, Shinji, Stoffel, Markus P., Benson, Joanne T.

    Published in Liver transplantation (01-02-2004)
    “…Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PortoPH) are pulmonary vascular consequences of advanced liver disease associated with…”
    Get full text
    Journal Article
  3. 3

    Long-term outcome of controlled, non-heart-beating donor liver transplantation by MANZARBEITIA, Cosme Y, ORTIZ, Jorge A, JEAN, Hoonbae, ROTHSTEIN, Kenneth D, MARTINEZ, Oscar, ARAYA, Victor R, MUNOZ, Santiago J, REICH, David J

    Published in Transplantation (27-07-2004)
    “…Previous reports have established the feasibility of using livers from controlled, non-heart-beating donors (CNHBD) with good immediate graft function. This…”
    Get full text
    Journal Article
  4. 4

    Controlled non-heart-beating donor liver transplantation : A successful single center experience, with topic update by REICH, David J, MUNOZ, Santiago J, ROTHSTEIN, Kenneth D, NATHAN, Howard M, EDWARDS, John M, HASZ, Richard D, MANZARBEITIA, Cosme Y

    Published in Transplantation (27-10-2000)
    “…The critical shortage of transplantable organs necessitates utilization of unconventional donors. We describe a successful experience of controlled…”
    Get full text
    Journal Article
  5. 5

    Fungal infections in solid organ transplant patients by Hagerty, Jennifer A, Ortiz, Jorge, Reich, David, Manzarbeitia, Cosme

    Published in Surgical infections (01-09-2003)
    “…Solid organ transplantation is becoming increasingly more common in the treatment of end-stage organ failure. Opportunistic fungal infections are a frequent…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Combined liver and pancreas procurement from a controlled non-heart-beating donor with aberrant hepatic arterial anatomy by JEON, Hoonbae, ORTIZ, Jorge A, MANZARBEITIA, Cosme Y, ALVAREZ, Sergio C, SUTHERLAND, David E. R, REICH, David J

    Published in Transplantation (15-12-2002)
    “…The critical shortage of transplantable organs has resulted in the use of extended donors, including non-heart-beating donors (NHBDs). Combined procurement of…”
    Get full text
    Journal Article
  8. 8

    Six year disease free survival after liver transplantation in a patient with T3 gallbladder carcinoma: case presentation and review of the literature by Ortiz, Jorge, Reich, David, Joon, Hoon Bae, Martinez, Oscar, Manzarbeitia, Cosme

    Published in World journal of surgical oncology (14-07-2006)
    “…The incidence of gallbladder carcinoma in cirrhotics is unknown. Known risk factors are primary sclerosing cholangitis and polypoid masses. A sixty year old…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Sonographic Diagnosis and Outcome of Hepatic Artery Thrombosis After Orthotopic Liver Transplantation in Adults by Horrow, Mindy M, Blumenthal, Beth M, Reich, David J, Manzarbeitia, Cosme

    Published in American journal of roentgenology (1976) (01-08-2007)
    “…The objective of our study was to determine the timing and frequency of symptomatic hepatic artery thrombosis in an adult orthotopic liver transplant…”
    Get full text
    Journal Article
  11. 11

    Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation by Pungpapong, Surakit, Manzarbeitia, Cosme, Ortiz, Jorge, Reich, David J., Araya, Victor, Rothstein, Kenneth D., Muñoz, Santiago J.

    Published in Liver transplantation (01-07-2002)
    “…Hepatic artery thrombosis (HAT) and other vascular complications are significant causes of morbidity after liver transplantation. Although cigarette smoking…”
    Get full text
    Journal Article
  12. 12

    Safe use of livers from donors with positive hepatitis B core antibody by Manzarbeitia, Cosme, Reich, David J., Ortiz, Jorge A., Rothstein, Kenneth D., Araya, Victor R., Munoz, Santiago J.

    Published in Liver transplantation (01-06-2002)
    “…Thirty-five patients received liver transplants using liver donors who had positive test results for the hepatitis B core antibody (HBcAb). In the same time…”
    Get full text
    Journal Article
  13. 13

    Successful Re‐Use of Liver Allografts: Three Case Reports and a Review of the UNOS Database by Ortiz, Jorge, Reich, David J., Manzarbeitia, Cosme, Humar, Abhinav

    Published in American journal of transplantation (01-01-2005)
    “…The donor organ shortage has compelled transplant centers to use organs from non‐traditional sources. One example is the re‐use of a previously transplanted…”
    Get full text
    Journal Article
  14. 14

    Liver transplantation for patients on methadone maintenance by Kanchana, Thirumalesh P., Kaul, Vivek, Manzarbeitia, Cosme, Reich, David J., Hails, Kevin C., Munoz, Santiago J., Rothstein, Kenneth D.

    Published in Liver transplantation (01-09-2002)
    “…Most transplant programs require abstinence of at least 6 months from alcohol and illicit drugs before orthotopic liver transplantation (OLT). However, there…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20